Ironwood Pharmaceuticals (IRWD) Change in Cash (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Change in Cash across 17 years of filings, most recently posting $5.0 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $5.0 million, down 74.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $112.0 million (up 957.57% YoY), and the FY2025 annual result was $126.9 million, up 3629.82% from the prior year.
• Change in Cash came in at $5.0 million for Q1 2026 at Ironwood Pharmaceuticals, down from $75.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $84.1 million in Q1 2023 to a low of -$565.5 million in Q2 2023.
• The 5-year median for Change in Cash is $348000.0 (2024), against an average of -$23.6 million.
• Across the five-year window, Change in Cash tumbled 535.3% in 2023 and soared 21465.8% in 2025, its largest moves.
• Ironwood Pharmaceuticals' Change in Cash stood at $82.0 million in 2022, then plunged by 123.54% to -$19.3 million in 2023, then jumped by 101.8% to $348000.0 in 2024, then jumped by 21465.8% to $75.0 million in 2025, then slumped by 93.32% to $5.0 million in 2026.
• The last three Change in Cash figures came in at $5.0 million (Q1 2026), $75.0 million (Q4 2025), and $47.6 million (Q3 2025), per Business Quant data.